Predictive Oncology Inc Asset Resilience Ratio
Predictive Oncology Inc asset resilience ratio. Predictive Oncology Inc (POAI) has an Asset Resilience Ratio of 4.08% as of March 2018. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See POAI days of operational coverage to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Predictive Oncology Inc (2016–2018)
Asset resilience ratio of Predictive Oncology Inc from 2016 to 2018. This chart shows how Predictive Oncology Inc's Asset Resilience Ratio has changed over time. Read Predictive Oncology Inc debt and liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Predictive Oncology Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see POAI asset base.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $244.97K | 4.08% |
| Total Liquid Assets | $244.97K | 4.08% |
Asset Resilience Insights
- Limited Liquidity: Predictive Oncology Inc maintains only 4.08% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Predictive Oncology Inc Industry Peers by Asset Resilience Ratio
Compare Predictive Oncology Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
TIZA Information Industry Corporation Inc
SHE:300209 |
Software - Infrastructure | 0.25% |
|
Payoneer Global Inc
NASDAQ:PAYO |
Software - Infrastructure | 85.26% |
|
Lakala Payment Co Ltd
SHE:300773 |
Software - Infrastructure | 9.88% |
|
Qi An Xin Technology Group Inc
SHG:688561 |
Software - Infrastructure | 1.17% |
|
Megaport Ltd
AU:MP1 |
Software - Infrastructure | 22.07% |
|
Shenzhen Ysstech Info-Tech Co Ltd
SHE:300377 |
Software - Infrastructure | 6.03% |
|
Maxvision Technology Corp
SHE:002990 |
Software - Infrastructure | 5.60% |
|
E2E Networks Limited
NSE:E2E |
Software - Infrastructure | 2.56% |
Predictive Oncology Inc Asset Resilience Ratio by Year (2016–2018)
Predictive Oncology Inc asset resilience ratio by year from 2016 to 2018. The table below shows the annual Asset Resilience Ratio data for Predictive Oncology Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2018-12-31 | 0.00% | $0.00 | $3.71 Million | -- |
| 2017-12-31 | 6.76% | $244.97K | $3.62 Million | -3.37pp |
| 2016-12-31 | 10.13% | $284.33K | $2.81 Million | -- |
About Predictive Oncology Inc
Predictive Oncology Inc., a knowledge and science-driven company, applies artificial intelligence (AI) to support the discovery and development of cancer therapies. It operates through two segments, Pittsburgh and Eagan. The Pittsburgh segment provides services that include the application of AI using its proprietary biobank of 150,000+ tumor samples. This segment also creates proprietary 3D cult… Read more